Age of Onset of Receptor Tyrosine Kinase Fusions Drives Distinct Biologic Outcomes in Thyroid Cancer

被引：4
|
作者：
Fagin, James A. [1 ,2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Weill Cornell Med Coll, Dept Med, 1275 York Ave, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Weill Cornell Med Coll, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10065 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 10期
关键词：
REARRANGEMENTS; CARCINOMA; CHILDREN;
D O I：
10.1200/JCO.21.02864
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1124 / +
页数：4
相关论文
共 50 条
  • [41] ETV6-NTRK3 and STRN-ALK kinase fusions are recurrent events in papillary thyroid cancer of adult population
    Bastos, Andre Uchimura
    de Jesus, Ana Carolina
    Cerutti, Janete Maria
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2018, 178 (01) : 83 - 91
  • [42] Real-World Efficacy and Safety of Multi-Tyrosine Kinase Inhibitors in Radioiodine Refractory Thyroid Cancer
    Koehler, Viktoria Florentine
    Berg, Elke
    Adam, Pia
    Weber, Gian-Luca
    Pfestroff, Andreas
    Luster, Markus
    Kutsch, Jana Maria
    Lapa, Constantin
    Sandner, Benjamin
    Rayes, Nada
    Fuss, Carmina Teresa
    Kreissl, Michael C.
    Hoster, Eva
    Allelein, Stephanie
    Schott, Matthias
    Todica, Andrei
    Fassnacht, Martin
    Kroiss, Matthias
    Spitzweg, Christine
    THYROID, 2021, 31 (10) : 1531 - 1541
  • [43] Novel Pyrazolopyrimidine Derivatives as Tyrosine Kinase Inhibitors with Antitumoral Activity in Vitro and in Vivo in Papillary Dedifferentiated Thyroid Cancer
    Antonelli, Alessandro
    Bocci, Guido
    La Motta, Concettina
    Ferrari, Silvia Martina
    Fallahi, Poupak
    Fioravanti, Anna
    Sartini, Stefania
    Minuto, Michele
    Piaggi, Simona
    Corti, Alessandro
    Ali, Greta
    Berti, Piero
    Fontanini, Gabriella
    Danesi, Romano
    Da Settimo, Federico
    Miccoli, Paolo
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (02) : E288 - E296
  • [44] Neoadjuvant tyrosine kinase inhibitor therapy in locally advanced differentiated thyroid cancer: a single centre case series
    Yeo, J. J. Y.
    Stewart, K.
    Maniam, P.
    Arman, S.
    Srinivasan, D.
    Wall, L.
    MacNeill, M.
    Strachan, M.
    Nixon, I
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2023, 137 (11) : 1237 - 1243
  • [45] Validation of a Phosphoprotein Array Assay for Characterization of Human Tyrosine Kinase Receptor Downstream Signaling in Breast Cancer
    Chergui, Fadila
    Chretien, Anne-Sophie
    Bouali, Sanae
    Ramacci, Carole
    Rouyer, Marie
    Bastogne, Thierry
    Genin, Pascal
    Leroux, Agnes
    Merlin, Jean-Louis
    CLINICAL CHEMISTRY, 2009, 55 (07) : 1327 - 1336
  • [46] Evidence for 2-Methoxyestradiol-Mediated Inhibition of Receptor Tyrosine Kinase RON in the Management of Prostate Cancer
    Batth, Izhar Singh
    Huang, Shih-Bo
    Villarreal, Michelle
    Gong, Jingjing
    Chakravarthy, Divya
    Keppler, Brian
    Jayamohan, Sridharan
    Osmulski, Pawel
    Xie, Jianping
    Rivas, Paul
    Bedolla, Roble
    Liss, Michael A.
    Yeh, I-Tien
    Reddick, Robert
    Miyamoto, Hiroshi
    Ghosh, Rita
    Kumar, Addanki P.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (04) : 1 - 18
  • [47] Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer
    Li, Meng
    Yang, Jingyu
    Zhou, Wenlong
    Ren, Yong
    Wang, Xiaoxuan
    Chen, Huiping
    Zhang, Jingyuan
    Chen, Junli
    Sun, Yuhong
    Cui, Lijuan
    Liu, Xing
    Wang, Lihui
    Wu, Chunfu
    BRITISH JOURNAL OF CANCER, 2017, 117 (07) : 974 - 983
  • [48] Non-receptor tyrosine kinase Etk is involved in the apoptosis of small cell lung cancer cells
    Guo, Linlang
    Chen, Pinglian
    Zhou, Yuanyuan
    Sun, Yanqin
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2010, 88 (03) : 401 - 406
  • [49] The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas
    S Klugbauer
    H M Rabes
    Oncogene, 1999, 18 : 4388 - 4393
  • [50] A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer
    Schlumberger, Martin
    Jarzab, Barbara
    Cabanillas, Maria E.
    Robinson, Bruce
    Pacini, Furio
    Ball, Douglas W.
    McCaffrey, Judith
    Newbold, Kate
    Allison, Roger
    Martins, Renato G.
    Licitra, Lisa F.
    Shah, Manisha H.
    Bodenner, Donald
    Elisei, Rossella
    Burmeister, Lynn
    Funahashi, Yasuhiro
    Ren, Min
    O'Brien, James P.
    Sherman, Steven I.
    CLINICAL CANCER RESEARCH, 2016, 22 (01) : 44 - 53
12345